» Articles » PMID: 2230644

Prooxidant Activity of Transferrin and Lactoferrin

Overview
Journal J Exp Med
Date 1990 Nov 1
PMID 2230644
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Acceleration of the autoxidation of Fe2+ by apotransferrin or apolactoferrin at acid pH is indicated by the disappearance of Fe2+, the uptake of oxygen, and the binding of iron to transferrin or lactoferrin. The product(s) formed oxidize iodide to an iodinating species and are bactericidal to Escherichia coli. Toxicity to E. coli by FeSO4 (10(-5) M) and human apotransferrin (100 micrograms/ml) or human apolactoferrin (25 micrograms/ml) was optimal at acid pH (4.5-5.0) and with logarithmic phase organisms. Both the iodinating and bactericidal activities were inhibited by catalase and the hydroxyl radical (OH.) scavenger mannitol, whereas superoxide dismutase was ineffective. NaCl at 0.1 M inhibited bactericidal activity, but had little or no effect on iodination. Iodide increased the bactericidal activity of Fe2+ and apotransferrin or apolactoferrin. The formation of OH.was suggested by the formation of the OH.spin-trap adduct (5,5-dimethyl-1-pyroline N-oxide [DMPO]/OH)., with the spin trap DMPO and the formation of the methyl radical adduct on the further addition of dimethyl sulfoxide. (DMPO/OH).formation was inhibited by catalase, whereas superoxide dismutase had little or no effect. These findings suggest that Fe2+ and apotransferrin or apolactoferrin can generate OH.via an H2O2 intermediate with toxicity to microorganisms, and raise the possibility that such a mechanism may contribute to the microbicidal activity of phagocytes.

Citing Articles

The Multifaceted Roles of Bovine Lactoferrin: Molecular Structure, Isolation Methods, Analytical Characteristics, and Biological Properties.

Dyrda-Terniuk T, Pomastowski P J Agric Food Chem. 2023; 71(51):20500-20531.

PMID: 38091520 PMC: 10755757. DOI: 10.1021/acs.jafc.3c06887.


Lactoferrin inhibits the proliferation of IMR‑32 neuroblastoma cells even under X‑rays.

Kato S Med Int (Lond). 2023; 3(4):33.

PMID: 37448769 PMC: 10336960. DOI: 10.3892/mi.2023.93.


Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.

Kontoghiorghes G Int J Mol Sci. 2022; 23(3).

PMID: 35163288 PMC: 8836132. DOI: 10.3390/ijms23031364.


Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications.

Kontoghiorghes G, Kolnagou A, Kontoghiorghe C, Mourouzidis L, Timoshnikov V, Polyakov N Medicines (Basel). 2020; 7(8).

PMID: 32751493 PMC: 7460366. DOI: 10.3390/medicines7080045.


Alterations in neonatal neutrophil function attributable to increased immature forms.

Makoni M, Eckert J, Pereira H, Nizet V, Lawrence S Early Hum Dev. 2016; 103:1-7.

PMID: 27428466 PMC: 5154866. DOI: 10.1016/j.earlhumdev.2016.05.016.


References
1.
BULLEN J, Rogers H, Leigh L . Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J. 1972; 1(5792):69-75. PMC: 1789269. DOI: 10.1136/bmj.1.5792.69. View

2.
Masson P, Heremans J, Prignot J, Wauters G . Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax. 1966; 21(6):538-44. PMC: 1019108. DOI: 10.1136/thx.21.6.538. View

3.
Baker E, Shaw D, Morgan E . Isolation and characterization of rabbit serum and milk transferrins. Evidence for difference in sialic acid content only. Biochemistry. 1968; 7(4):1371-8. DOI: 10.1021/bi00844a019. View

4.
ORAM J, Reiter B . Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta. 1968; 170(2):351-65. DOI: 10.1016/0304-4165(68)90015-9. View

5.
Aisen P, Leibman A . Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta. 1972; 257(2):314-23. DOI: 10.1016/0005-2795(72)90283-8. View